Hjem › Lungesykdommer › Texas › Houston
Kliniske studier for Lungesykdommer i Houston, TX
15 studier for Lungesykdommer søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of COVID-19 Vaccine(s) in Children and Adults
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
- DM Clinical Research-Cyfair, Houston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RekruttererFase 3
- Memorial Hermann Hospital TMC, Houston
- The University of Texas Health Science Center at Houston, Houston
- UT Physicians, Houston
- og 4 flere
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RekruttererFase 3
- Cockrell Center for Advanced Therapeutics, Houston
- Houston Methodist - Transplant Center, Houston
- Houston Methodist Hospital, Houston
- og 4 flere
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekruttererFase 2
- Baylor College of Medicine Medical Center, Houston
American Lung Association (ALA) Lung Health Cohort
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Baylor College of Medicine, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- MD Anderson, Houston
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
RekruttererFase 2
- Greater Heights & Memorial Pulmonary and Sleep, Houston
- Houston Pulmonary Sleep and Allergy Associates, Houston
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Site 1005, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RekruttererFase 3
- GSK Investigational Site, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RekruttererFase 2
- Baylor College of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RekruttererFase 2
- Clinical Research Site, Houston
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
RekruttererFase 2
- University of Texas MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekrutterer
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Lungesykdommer-studier i andre byer
- Boston, MA14 studier
- Durham, NC13 studier
- New York City, NY12 studier
- Pittsburgh, PA11 studier
- Dallas, TX10 studier
- Nashville, TN10 studier
- Columbus, OH10 studier
- Los Angeles, CA10 studier
- Washington, DC10 studier
- Miami, FL10 studier
- Ann Arbor, MI10 studier
- Chicago, IL9 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.